Associated Papers
Prognosis and risk factors for ASXL1 mutations in patients with newly diagnosed acute myeloid leukemia and myelodysplastic syndrome.
Yang L et al.
Cancer Medicine, 2024
ASXL1 mutations predict inferior molecular response to nilotinib treatment in chronic myeloid leukemia.
Schönfeld L et al.
Leukemia, 2022
35902731 (PubMed )
Supplement: 41375_2022_1648_MOESM1_ESM.xlsx › Clinical_data
Mouse Models of Frequently Mutated Genes in Acute Myeloid Leukemia.
Mohanty S et al.
Cancers, 2021
The ASXL1-G643W variant accelerates the development of CEBPA mutant acute myeloid leukemia.
D'Altri T et al.
Haematologica, 2021
Select a paper to view details